SecBot SecBot
SECBOTREPLAY Home › Report › PASG

PASG · Passage Bio, Inc

Passage BIO, Inc. · DEFA14A filed Apr 7, 2026 at 07:01 ET

At the news

NEUTRALIMPACT 2/10

DEFA14A filed Apr 7, 2026 at 07:01 ET

Passage Bio, Inc. filed a definitive proxy statement for its 2026 Annual Meeting, which includes the election of two Class III directors, ratification of its independent auditor, and approval of executive compensation. This is a routine corporate governance filing.

  • Election of two Class III directors: Athena Countouriotis, M.D. and Sandip Kapadia
  • Ratification of KPMG LLP as independent registered public accounting firm for fiscal year 2026
  • Approval of executive officer compensation on a non-binding advisory basis
  • Approval of frequency for future advisory votes on executive compensation

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access